Mylan, the embattled maker of allergy treatment EpiPen, lowered its 2016 earnings guidance Friday after it agreed to pay $465 million in a settlement with federal regulators over its pricing ...

When Mylan dramatically increased the price of its life-saving EpiPen devices, it drew sharp rebuke all around for what seemed like a purely greedy—and heartless—move. But according to a ...

Jan 16 (Reuters) - Mylan has agreed to pay $73.5 million to settle a class action lawsuit by drug wholesalers accusing the drugmaker of scheming to overcharge them for EpiPen allergy treatment ...

The EpiPen’s been around since 1977, but Mylan acquired the autoinjector—which precisely calibrates the epinephrine dosage—in 2007. The patient now pays about 400% more for this advantage to ...

It’s not surprising that EpiPen maker Mylan would defend its 400% price increase with the line that it’s okay because it’s generally covered by insurance. That’s the pharmaceutical ...

EpiPen prices aren't the only thing to jump at Mylan. Executive salaries have also seen a stratospheric uptick. Proxy filings show that from 2007 to 2015, Mylan CEO Heather Bresch's total ...

Pharmaceutical giant Mylan has raised the price of the EpiPen more than 500% over the last six years, leaving parents shocked and scrambling to buy the injection device for children with life ...

EpiPen maker Mylan announced Monday morning that it would introduce a generic version of the lifesaving allergy injection at half the price of the brand-name product, after politicians blasted ...

Mylan may have overcharged taxpayers as much as $1.27 billion over 10 years for its signature EpiPens, according to an analysis released Wednesday by the Department of Health and Human Services ...

Mylan CEO Heather Bresch responds to questions from the House Oversight Committee regarding costs of the EpiPen. The company raised the list price of the allergy medication 548% over the last nine ...